A new New Zealand Journal of Geology and Geophysics paper out today describes th...
Investigators from the Smidt Heart Institute at Cedars-Sinai are one step closer...
A new study in mice shows that consuming emulsifiers—a common ingredient in ultr...
Mallinckrodt has publicly disclosed its imminent initiation of the next phase of...
Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlig...
Medtronic’s pursuit of FDA approval for its blood pressure treatment device has ...
Novo Nordisk is eyeing the cardiology treatment space for its highly sought-afte...
The US Food and Drug Administration's recent accelerated approval of Pfizer's El...
Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the...
The US Food and Drug Administration (FDA) has granted clearance to Gilead Scienc...
In light of the conviction of UK nurse Lucy Letby for murder, doctors are callin...
Patient data sharing among various stakeholders for research purposes forms the ...
Merck (MSD) and AstraZeneca have received approval in Japan for Lynparza to trea...
The Sandoz biosimilar, Tyruko, was approved by the US FDA for all labelled indic...
The latest fundraise will close in 2024, with plans for one Phase II trial to st...
Soliris is already approved to treat refractory generalised myasthenia gravis in...
